Alterity Therapeutics shares are trading higher after Jones Trading initiated coverage on the stock with a Buy rating and announced a $16 pr
Alterity Therapeutics shares are trading higher after Jones Trading initiated coverage on the stock with a Buy rating and announced a $16 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.